GORE CARDIOFORM ASD Occluder. cardiovascular implant.

FDA Device Recall #Z-0136-2023 — Class II — September 21, 2022

Recall Summary

Recall Number Z-0136-2023
Classification Class II — Moderate risk
Date Initiated September 21, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm W L Gore & Associates, Inc.
Location Flagstaff, AZ
Product Type Devices
Quantity 98 units

Product Description

GORE CARDIOFORM ASD Occluder. cardiovascular implant.

Reason for Recall

Due to manufacturing records (Release Test Results) indicating "Failed".

Distribution Pattern

Worldwide distribution - U.S. Nationwide distribution including in the states of AZ, CA, CO, DC, FL, GA, IA, ID, IL, ME, MN, NC, NY, JPA, TN, TX, WA, and WI. The countries of Denmark, and Japan.

Lot / Code Information

Model Numbers: ASD37A UDI-DI Codes: 00733132636501 Serial Numbers: 24468090 24468092 24468093 24468096 24468097 24468098 24468099 24468103 24468104 24480314 24480315 24480316 24480318 24468102 24468094 24468100 24468101 24480317 24468091 24468095 Model Number: ASD44A UDI-DI Code: 00733132636518 Serial Numbers: 24281498 24281499 24281500 24281501 24281502 24281507 24281509 24281511 24281512 24429270 24429271 24429276 24429278 24429279 24480351 24480352 24480353 24545359 24550148 24550149 24578446 24578447 24281506 24429272 24429273 24429274 24429277 24545360 24545362 24550147 24550150 24550151 24578443 24578445 24281503 24281504 24281505 24281508 24281510 24429275 24480354 24480355 24545358 Model Number: ASD44E UDI-DI Code: 00733132636617 Serial Numbers: 24305083 24305081 24550693 24550694 24305079 24305080 24305082 24550695 24550696 24550697

Other Recalls from W L Gore & Associates, Inc.

Recall # Classification Product Date
Z-0036-2026 Class II GORE ACUSEAL Vascular Graft, REF: ECH050020J, E... Aug 26, 2025
Z-2945-2024 Class II Heparin, Gore Viabahn VBX, Balloon Expandable E... Jul 1, 2024
Z-2946-2024 Class II Heparin, Gore Viabahn VBX, Balloon Expandable E... Jul 1, 2024
Z-1048-2023 Class II GORE CARDIOFORM Septal Occluder, REF: GSX0030A Dec 14, 2022
Z-0077-2022 Class II Heparin, GORE VIABAHN VBX, BALLOON EXPANDABLE E... Sep 7, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.